PRAME and acute myeloid leukemia: We found several peptides from proteins known to be dysregulated in DIPG, including IL13Rα2, PRAME, and MAGE, which are also known to generate strong, anti-tumor responses in neuroblastoma and acute myeloid leukemia (83, 84).